Privia Health Group (NASDAQ:PRVA) Given "Buy" Rating at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Privia Health Group (NASDAQ:PRVA - Free Report) in a report issued on Friday morning,Benzinga reports. Needham & Company LLC currently has a $30.00 price objective on the stock.

Several other research firms also recently commented on PRVA. Piper Sandler lifted their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research report on Friday, February 28th. Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price target for the company. Stephens reaffirmed an "overweight" rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a report on Friday, November 29th. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Privia Health Group currently has a consensus rating of "Buy" and an average price target of $26.67.

Remove Ads

Privia Health Group Trading Down 4.9 %

Shares of PRVA traded down $1.17 during midday trading on Friday, reaching $22.75. The stock had a trading volume of 1,120,538 shares, compared to its average volume of 754,617. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 227.52, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The company's 50-day moving average is $23.75 and its 200 day moving average is $21.11. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04.

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. First Horizon Advisors Inc. increased its position in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after purchasing an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after purchasing an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. purchased a new position in shares of Privia Health Group during the fourth quarter valued at about $51,000. Quarry LP raised its stake in Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after buying an additional 2,533 shares in the last quarter. Finally, KBC Group NV raised its stake in Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after buying an additional 871 shares in the last quarter. Institutional investors own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.